# Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

> **NCT07695389** · NA · RECRUITING · sponsor: **BioLab Holdings** · enrollment: 160 (estimated)

## Conditions studied

- Mohs Micrographic Surgery
- Cutaneous Malignancy
- Mohs Surgical Defect

## Interventions

- **OTHER:** Control Dressing + Standard of Care
- **OTHER:** CAMP + Standard of Care

## Key facts

- **NCT ID:** NCT07695389
- **Lead sponsor:** BioLab Holdings
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-18
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695389, "Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*